Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Daisy Alapat

Concepts (252)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
30
2025
3049
1.920
Why?
Flow Cytometry
5
2018
404
0.910
Why?
Immunoglobulins
2
2018
76
0.680
Why?
Plasma Cells
3
2025
239
0.650
Why?
Immunoglobulin kappa-Chains
2
2016
22
0.610
Why?
Bone Marrow
7
2022
364
0.570
Why?
Monoclonal Gammopathy of Undetermined Significance
4
2025
125
0.570
Why?
DNA, Neoplasm
1
2018
146
0.550
Why?
Hematopoietic Stem Cell Transplantation
4
2024
606
0.520
Why?
Lymphoma, Large B-Cell, Diffuse
2
2015
106
0.520
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
2
2016
59
0.490
Why?
Immunoglobulin lambda-Chains
1
2015
15
0.480
Why?
Neoplasm, Residual
6
2025
173
0.480
Why?
Gene Rearrangement, B-Lymphocyte
1
2015
6
0.470
Why?
Receptors, Antigen, B-Cell
1
2015
7
0.470
Why?
Tumor Microenvironment
4
2024
255
0.440
Why?
Humans
50
2025
52336
0.390
Why?
Plasmacytoma
3
2022
43
0.380
Why?
Cell Differentiation
1
2015
674
0.380
Why?
Lymphoma, Mantle-Cell
1
2012
18
0.370
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2012
12
0.370
Why?
Carcinoembryonic Antigen
1
2011
13
0.360
Why?
Calcitonin
1
2011
30
0.350
Why?
Antigens, CD
1
2012
219
0.340
Why?
Middle Aged
20
2025
13014
0.320
Why?
Prognosis
9
2025
2094
0.320
Why?
Carcinoma
1
2011
137
0.320
Why?
Myogenin
1
2008
4
0.310
Why?
Muscle Fibers, Slow-Twitch
1
2008
12
0.300
Why?
Muscle Fibers, Fast-Twitch
1
2008
14
0.300
Why?
Paraproteinemias
2
2022
74
0.290
Why?
Gene Expression Profiling
4
2025
1110
0.280
Why?
Positron-Emission Tomography
3
2025
303
0.270
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2024
1031
0.270
Why?
Neoplasms, Second Primary
2
2019
77
0.260
Why?
Aged
18
2025
10109
0.250
Why?
Female
23
2025
28105
0.240
Why?
Male
20
2025
26696
0.240
Why?
Treatment Outcome
10
2022
5407
0.230
Why?
Pancytopenia
3
2016
38
0.230
Why?
Diffusion Magnetic Resonance Imaging
1
2025
133
0.230
Why?
Gastrointestinal Neoplasms
1
2022
42
0.190
Why?
Embolization, Therapeutic
2
2021
88
0.190
Why?
Neoplasms, Plasma Cell
2
2020
37
0.190
Why?
Thrombocytopenia
1
2022
89
0.180
Why?
Cryosurgery
1
2021
36
0.180
Why?
Chromosome Deletion
2
2023
142
0.180
Why?
Skin Neoplasms
2
2016
500
0.170
Why?
Transplantation, Autologous
4
2024
488
0.160
Why?
Adult
11
2025
14139
0.160
Why?
Combined Modality Therapy
1
2021
636
0.160
Why?
Ploidies
1
2018
10
0.140
Why?
Phenotype
2
2025
799
0.140
Why?
Hematopoietic Stem Cells
1
2019
188
0.140
Why?
Kidney Diseases
1
2020
220
0.140
Why?
Leukemia, Myeloid, Acute
1
2019
203
0.140
Why?
Herpesvirus 8, Human
1
2019
98
0.140
Why?
Sarcoma, Myeloid
1
2017
20
0.140
Why?
Chromosomes, Human, Pair 17
1
2017
35
0.140
Why?
Immunohistochemistry
3
2016
985
0.130
Why?
Lymph Nodes
2
2019
252
0.130
Why?
Amyloidosis
2
2016
85
0.130
Why?
Cell Cycle
1
2018
240
0.130
Why?
CA-125 Antigen
1
2016
16
0.130
Why?
Registries
3
2025
580
0.130
Why?
Disease Progression
4
2025
870
0.130
Why?
Skin Diseases, Infectious
1
2016
7
0.130
Why?
Leukemia, Promyelocytic, Acute
1
2016
12
0.130
Why?
Anemia, Aplastic
1
2016
11
0.130
Why?
Myeloproliferative Disorders
1
2016
31
0.120
Why?
Electrophoresis, Capillary
1
2015
10
0.120
Why?
In Situ Hybridization
1
2015
69
0.120
Why?
Tumor Suppressor Protein p53
1
2017
224
0.120
Why?
V(D)J Recombination
1
2015
4
0.120
Why?
Immunophenotyping
1
2015
117
0.120
Why?
Diagnosis, Differential
3
2016
1044
0.120
Why?
RNA, Messenger
2
2015
1142
0.120
Why?
Fatal Outcome
1
2015
196
0.110
Why?
Bone Marrow Transplantation
2
2022
113
0.110
Why?
Immunoglobulin Light Chains
1
2015
90
0.110
Why?
Prealbumin
1
2014
22
0.110
Why?
Bone Marrow Neoplasms
1
2014
13
0.110
Why?
Neoplasm Proteins
1
2016
334
0.110
Why?
Aged, 80 and over
5
2025
3391
0.110
Why?
Polymerase Chain Reaction
1
2015
460
0.110
Why?
Hodgkin Disease
1
2014
49
0.110
Why?
Parvoviridae Infections
1
2013
20
0.100
Why?
Parvovirus B19, Human
1
2013
17
0.100
Why?
Partial Thromboplastin Time
1
2012
13
0.100
Why?
Prothrombin Time
1
2012
17
0.100
Why?
Retrospective Studies
5
2025
6578
0.100
Why?
Afibrinogenemia
1
2012
5
0.100
Why?
Cardiomyopathies
1
2014
123
0.100
Why?
Immunoglobulins, Intravenous
1
2013
63
0.100
Why?
Predictive Value of Tests
1
2015
943
0.100
Why?
Plasma Exchange
1
2012
25
0.100
Why?
Retroperitoneal Neoplasms
1
2012
18
0.100
Why?
Glycoproteins
1
2012
123
0.100
Why?
Gene Expression Regulation, Neoplastic
1
2016
858
0.100
Why?
Precursor Cells, B-Lymphoid
1
2012
8
0.090
Why?
Histoplasma
1
2011
24
0.090
Why?
Antigens, Fungal
1
2011
20
0.090
Why?
Longitudinal Studies
2
2024
741
0.090
Why?
Immunoenzyme Techniques
1
2011
137
0.090
Why?
Hepatitis C
1
2012
79
0.090
Why?
Histoplasmosis
1
2011
47
0.090
Why?
Carcinoma, Neuroendocrine
1
2011
25
0.090
Why?
In Situ Hybridization, Fluorescence
3
2023
263
0.090
Why?
Dose-Response Relationship, Drug
2
2016
1377
0.080
Why?
Splenic Neoplasms
1
2009
2
0.080
Why?
Gene Expression
1
2012
623
0.080
Why?
Thyroid Neoplasms
1
2011
116
0.080
Why?
Myelodysplastic Syndromes
1
2009
86
0.080
Why?
Mutagenesis, Site-Directed
1
2008
98
0.080
Why?
Hemangioma
1
2009
84
0.070
Why?
Tomography, X-Ray Computed
3
2023
1162
0.070
Why?
HIV Infections
1
2012
388
0.070
Why?
Survival Analysis
2
2021
671
0.070
Why?
Protein Processing, Post-Translational
1
2008
158
0.070
Why?
Cells, Cultured
2
2008
1589
0.070
Why?
Stem Cell Transplantation
2
2022
185
0.070
Why?
Adolescent
2
2025
6692
0.070
Why?
Graft vs Host Disease
1
2007
88
0.070
Why?
Muscle Proteins
1
2008
347
0.060
Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
2005
34
0.060
Why?
Semaphorin-3A
1
2004
2
0.060
Why?
p38 Mitogen-Activated Protein Kinases
1
2005
95
0.060
Why?
Nerve Degeneration
1
2004
24
0.060
Why?
Acid Anhydride Hydrolases
1
2004
14
0.060
Why?
Mitogen-Activated Protein Kinase 3
1
2004
49
0.060
Why?
Mitogen-Activated Protein Kinase 1
1
2004
50
0.060
Why?
ROC Curve
1
2025
251
0.060
Why?
Antineoplastic Agents
1
2013
1222
0.060
Why?
Imidazoles
1
2005
124
0.060
Why?
Muscle, Smooth, Vascular
1
2005
137
0.060
Why?
Ferritins
1
2024
36
0.050
Why?
Killer Cells, Natural
1
2024
116
0.050
Why?
Pyridines
1
2005
133
0.050
Why?
Myeloid Progenitor Cells
1
2023
17
0.050
Why?
Pyrimidines
1
2005
199
0.050
Why?
Cost of Illness
1
2024
120
0.050
Why?
Gene Expression Regulation
1
2008
1006
0.050
Why?
CD8-Positive T-Lymphocytes
1
2024
132
0.050
Why?
Enzyme Inhibitors
1
2005
374
0.050
Why?
Adrenal Cortex Hormones
1
2023
114
0.050
Why?
Hippocampus
1
2004
201
0.050
Why?
Chromosomes, Human, Pair 1
1
2023
96
0.050
Why?
Case-Control Studies
2
2019
1201
0.050
Why?
Transcriptome
1
2025
367
0.050
Why?
Cohort Studies
2
2020
1532
0.050
Why?
Chromosome Aberrations
1
2023
297
0.050
Why?
Dexamethasone
1
2024
440
0.050
Why?
Mediastinum
1
2021
21
0.050
Why?
Gastrointestinal Tract
1
2022
108
0.050
Why?
Fever
1
2022
112
0.050
Why?
Neurons
1
2004
418
0.050
Why?
Vincristine
1
2021
88
0.050
Why?
T-Lymphocytes
1
2023
340
0.040
Why?
Axilla
1
2021
92
0.040
Why?
Prednisone
1
2021
102
0.040
Why?
Pelvis
1
2021
69
0.040
Why?
Time Factors
2
2017
2957
0.040
Why?
Cyclophosphamide
1
2021
171
0.040
Why?
Radiopharmaceuticals
1
2021
205
0.040
Why?
Alzheimer Disease
1
2004
331
0.040
Why?
Signal Transduction
2
2004
1716
0.040
Why?
Fluorodeoxyglucose F18
1
2021
188
0.040
Why?
Tumor Burden
1
2020
136
0.040
Why?
Mice
3
2023
5965
0.040
Why?
Doxorubicin
1
2021
239
0.040
Why?
Antibodies, Monoclonal
1
2023
481
0.040
Why?
False Negative Reactions
1
2019
30
0.040
Why?
Hospitalization
1
2024
732
0.040
Why?
Cell Line, Tumor
1
2023
1436
0.040
Why?
Herpesvirus 4, Human
1
2019
44
0.040
Why?
Epstein-Barr Virus Infections
1
2019
33
0.040
Why?
Phosphorylation
3
2005
531
0.040
Why?
Herpesviridae Infections
1
2019
57
0.040
Why?
Genome, Viral
1
2019
83
0.040
Why?
DNA, Viral
1
2019
138
0.040
Why?
Virus Diseases
1
2019
45
0.040
Why?
Follow-Up Studies
1
2024
2268
0.040
Why?
Neoplasm Recurrence, Local
1
2022
643
0.040
Why?
Liver
1
2022
1159
0.030
Why?
Scleromyxedema
1
2016
4
0.030
Why?
Schnitzler Syndrome
1
2016
4
0.030
Why?
Cryoglobulinemia
1
2016
13
0.030
Why?
Xanthomatosis
1
2016
10
0.030
Why?
Asymptomatic Diseases
1
2016
38
0.030
Why?
POEMS Syndrome
1
2016
34
0.030
Why?
Melphalan
1
2016
181
0.030
Why?
Disease-Free Survival
1
2016
460
0.030
Why?
Young Adult
1
2025
4319
0.030
Why?
Animals
3
2023
13523
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2015
186
0.030
Why?
Reed-Sternberg Cells
1
2014
2
0.030
Why?
HIV Seronegativity
1
2014
3
0.030
Why?
Karyotype
1
2014
19
0.030
Why?
Thalidomide
1
2016
377
0.030
Why?
Fusion Proteins, bcr-abl
1
2014
20
0.030
Why?
Cell Division
2
2005
291
0.030
Why?
Heterozygote
1
2014
91
0.030
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2014
45
0.030
Why?
Mutation
1
2019
1351
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2015
583
0.030
Why?
Oligonucleotide Array Sequence Analysis
1
2015
412
0.030
Why?
Remission Induction
1
2014
218
0.030
Why?
Fibrinogen
1
2012
34
0.030
Why?
Blood Coagulation
1
2012
60
0.020
Why?
Risk Assessment
1
2017
1323
0.020
Why?
Survival Rate
1
2015
940
0.020
Why?
Neoplasm Staging
1
2015
770
0.020
Why?
Reference Values
1
2012
313
0.020
Why?
Biopsy
1
2014
604
0.020
Why?
Antibodies, Fungal
1
2011
2
0.020
Why?
Mycological Typing Techniques
1
2011
3
0.020
Why?
Cross Reactions
1
2011
41
0.020
Why?
Lung Diseases, Fungal
1
2011
20
0.020
Why?
Immunocompromised Host
1
2011
123
0.020
Why?
Splenectomy
1
2009
36
0.020
Why?
Severity of Illness Index
1
2012
1021
0.020
Why?
Sensitivity and Specificity
1
2011
879
0.020
Why?
Blood Transfusion
1
2009
128
0.020
Why?
Transplantation, Isogeneic
1
2007
2
0.020
Why?
Laparoscopy
1
2009
180
0.020
Why?
Mice, Inbred C3H
1
2007
83
0.020
Why?
Cyclosporine
1
2007
67
0.020
Why?
Mice, SCID
1
2007
182
0.020
Why?
Magnetic Resonance Imaging
1
2014
1543
0.020
Why?
Models, Animal
1
2007
228
0.020
Why?
Immunosuppressive Agents
1
2007
243
0.010
Why?
Macromolecular Substances
1
2004
33
0.010
Why?
Physical Chromosome Mapping
1
2004
8
0.010
Why?
tau Proteins
1
2004
26
0.010
Why?
Genetic Complementation Test
1
2004
47
0.010
Why?
Epitopes
1
2004
65
0.010
Why?
Epidermal Growth Factor
1
2004
37
0.010
Why?
Microtubule-Associated Proteins
1
2004
65
0.010
Why?
Catalytic Domain
1
2004
61
0.010
Why?
Cricetulus
1
2004
104
0.010
Why?
Mutagenesis
1
2004
61
0.010
Why?
Cricetinae
1
2004
194
0.010
Why?
Cloning, Molecular
1
2004
191
0.010
Why?
Intercellular Signaling Peptides and Proteins
1
2004
106
0.010
Why?
Receptors, Cell Surface
1
2004
113
0.010
Why?
RNA
1
2004
172
0.010
Why?
Cell Survival
1
2005
602
0.010
Why?
Amino Acid Sequence
1
2004
591
0.010
Why?
Molecular Sequence Data
1
2004
792
0.010
Why?
Nerve Tissue Proteins
1
2004
193
0.010
Why?
Mice, Inbred C57BL
1
2007
1903
0.010
Why?
Cell Line
1
2004
1045
0.010
Why?
Alapat's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description